Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H
HHKEX:337826.78
HKD
-0.18
(-0.67%)
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H
HKEX:3378
(Hong Kong Exchange)
Recent
price
26.78
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.- Similar Companies
- Business
- Xiamen International Port Co., Ltd. is a leading port operator in China, principally engaged in container loading and unloading and storage; bulk and general cargo loading and unloading and storage; ancillary value-added port services including port-related logistics, shipping agency, tugboat berthing and unberthing, and tallying; manufacturing and selling of building materials; and trading business of merchandise. The company operates through key terminals such as Haitian Terminal, XICT, Hairun Terminal, XHICT, and Dongdu Terminal in the Dongdu and Haicang port areas of Xiamen City, with additional operations in Qingzhou operating area in Fuzhou, Quanzhou port, and self-owned berths in Sanbaimen new port area of Chaozhou City, Guangdong Province; it also provides agency services for international air transportation through subsidiaries and focuses on customers in international and domestic trade across the People's Republic of China. Founded in 1998 and headquartered at 127 Dongdu Road, Xiamen, Fujian Province, the company, which listed its H-shares on the Hong Kong Stock Exchange in 2005, employs 7,212 staff and maintains a parent-subsidiary relationship with Xiamen Port Development Co., Ltd., its controlling entity. In a significant recent development, Xiamen Port Development Co., Ltd., a subsidiary, agreed in August 2025 to acquire a 70% stake in Xiamen Container Terminal Group Co., Ltd. from Xiamen International Port Co., Ltd. for CNY 7.6 billion in a mixed cash and share transaction subject to regulatory approvals, aimed at consolidating container terminal operations.